Self-Reported Practices and Emotions in Prescribing Opioids for Chronic Noncancer Pain: A Cross-Sectional Study of German Physicians

Overview

Journal J Clin Med

Specialty General Medicine

Date 2022 May 14

PMID 35566644

Authors

Erika Schulte

Frank Petzke

Claudia Spies

Claudia Denke

Michael Schafer

Norbert Donner-Banzhoff

Ralph Hertwig

Odette Wegwarth

Affiliations

Soon will be listed here.

Abstract

Background: The pressure on physicians when a patient seeks pain relief and their own desire to be self-effective may lead to the prescription of strong opioids for chronic noncancer pain (CNCP). This study, via physician self-reporting, aims to identify and measure (i) physician adherence to national opioid prescribing guidelines and (ii) physician emotions when a patient seeks a dosage increase of the opioid. Methods: Within a cross-sectional survey—conducted as part of a randomized controlled online intervention trial (ERONA)—600 German physicians were queried on their opioid prescribing behavior (choice and formulation of opioid, indications) for CNCP patients and their emotions to a case vignette describing a patient seeking an opioid dosage increase without signs of objective deterioration. Results: The prescription of strong opioids in this study was not always in accordance with current guidelines. When presented with a scenario in which a patient sought to have their opioid dose increased, some physicians reported negative feelings, such as either pressure (25%), helplessness (25%), anger (23%) or a combination. The risk of non-guideline-compliant prescribing behavior using the example of ultrafast-acting fentanyl for CNCP was increased when negative emotions were present (OR: 1.7; 95%-CI: 1.2−2.6; p = 0.007) or when sublingual buprenorphine was prescribed (OR: 15.4; 95%-CI: 10.1−23.3; p < 0.001). Conclusions: Physicians’ emotional self-awareness represents the first step to identify such direct reactions to patient requests and to ensure a responsible, guideline-based opioid prescription approach for the long-term well-being of the patient.

References

Spitz A, Moore A, Papaleontiou M, Granieri E, Turner B, Reid M . Primary care providers' perspective on prescribing opioids to older adults with chronic non-cancer pain: a qualitative study. BMC Geriatr. 2011; 11:35. PMC: 3212901. DOI: 10.1186/1471-2318-11-35. View

Ramirez-Maestre C, Reyes-Perez A, Esteve R, Lopez-Martinez A, Bernardes S, Jensen M . Opioid Pain Medication Prescription for Chronic Pain in Primary Care Centers: The Roles of Pain Acceptance, Pain Intensity, Depressive Symptoms, Pain Catastrophizing, Sex, and Age. Int J Environ Res Public Health. 2020; 17(17). PMC: 7503487. DOI: 10.3390/ijerph17176428. View

Bialas P, Maier C, Klose P, Hauser W . Efficacy and harms of long-term opioid therapy in chronic non-cancer pain: Systematic review and meta-analysis of open-label extension trials with a study duration ≥26 weeks. Eur J Pain. 2019; 24(2):265-278. DOI: 10.1002/ejp.1496. View

Chaparro L, Furlan A, Deshpande A, Mailis-Gagnon A, Atlas S, Turk D . Opioids compared to placebo or other treatments for chronic low-back pain. Cochrane Database Syst Rev. 2013; (8):CD004959. PMC: 11056234. DOI: 10.1002/14651858.CD004959.pub4. View

Fleischman W, Auth D, Shah N, Agrawal S, Ross J . Association of a Risk Evaluation and Mitigation Strategy Program With Transmucosal Fentanyl Prescribing. JAMA Netw Open. 2019; 2(3):e191340. PMC: 6450314. DOI: 10.1001/jamanetworkopen.2019.1340. View

Oliveira C, Maher C, Pinto R, Traeger A, Lin C, Chenot J . Clinical practice guidelines for the management of non-specific low back pain in primary care: an updated overview. Eur Spine J. 2018; 27(11):2791-2803. DOI: 10.1007/s00586-018-5673-2. View

McDermott K, Griffin M, McHugh R, Fitzmaurice G, Jamison R, Provost S . Long-term naturalistic follow-up of chronic pain in adults with prescription opioid use disorder. Drug Alcohol Depend. 2019; 205:107675. DOI: 10.1016/j.drugalcdep.2019.107675. View

Miceli L, Bednarova R, DI Cesare M, Santori E, Spizzichino M, Di Minco L . Outpatient therapeutic chronic opioid consumption in Italy: a one-year survey. Minerva Anestesiol. 2016; 83(1):33-40. DOI: 10.23736/S0375-9393.16.11099-5. View

Alenezi A, Yahyouche A, Paudyal V . Current status of opioid epidemic in the United Kingdom and strategies for treatment optimisation in chronic pain. Int J Clin Pharm. 2020; 43(2):318-322. PMC: 8079300. DOI: 10.1007/s11096-020-01205-y. View

10.

Muench J, Fankhauser K, Voss R, Huguet N, Hartung D, OMalley J . Assessment of Opioid Prescribing Patterns in a Large Network of US Community Health Centers, 2009 to 2018. JAMA Netw Open. 2020; 3(9):e2013431. PMC: 7501536. DOI: 10.1001/jamanetworkopen.2020.13431. View

11.

Garland E, Froeliger B, Zeidan F, Partin K, Howard M . The downward spiral of chronic pain, prescription opioid misuse, and addiction: cognitive, affective, and neuropsychopharmacologic pathways. Neurosci Biobehav Rev. 2013; 37(10 Pt 2):2597-607. PMC: 3967721. DOI: 10.1016/j.neubiorev.2013.08.006. View

12.

Petzke F, Klose P, Welsch P, Sommer C, Hauser W . Opioids for chronic low back pain: An updated systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks of double-blind duration. Eur J Pain. 2019; 24(3):497-517. DOI: 10.1002/ejp.1519. View

13.

Furlan A, Sandoval J, Mailis-Gagnon A, Tunks E . Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ. 2006; 174(11):1589-94. PMC: 1459894. DOI: 10.1503/cmaj.051528. View

14.

Hossain M, Asamoah-Boaheng M, Badejo O, Bell L, Buckley N, Busse J . Prescriber adherence to guidelines for chronic noncancer pain management with opioids: Systematic review and meta-analysis. Health Psychol. 2020; 39(5):430-451. DOI: 10.1037/hea0000830. View

15.

Dowell D, Haegerich T, Chou R . CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. JAMA. 2016; 315(15):1624-45. PMC: 6390846. DOI: 10.1001/jama.2016.1464. View

16.

Passik S, Kirsh K . The interface between pain and drug abuse and the evolution of strategies to optimize pain management while minimizing drug abuse. Exp Clin Psychopharmacol. 2008; 16(5):400-4. DOI: 10.1037/a0013634. View

17.

Pierce M, van Amsterdam J, Kalkman G, Schellekens A, van den Brink W . Is Europe facing an opioid crisis like the United States? An analysis of opioid use and related adverse effects in 19 European countries between 2010 and 2018. Eur Psychiatry. 2021; 64(1):e47. PMC: 8316471. DOI: 10.1192/j.eurpsy.2021.2219. View

18.

Nury E, Schmucker C, Nagavci B, Motschall E, Nitschke K, Schulte E . Efficacy and safety of strong opioids for chronic noncancer pain and chronic low back pain: a systematic review and meta-analyses. Pain. 2021; 163(4):610-636. DOI: 10.1097/j.pain.0000000000002423. View

19.

Caverly T, Prochazka A, Combs B, Lucas B, Mueller S, Kutner J . Doctors and numbers: an assessment of the critical risk interpretation test. Med Decis Making. 2014; 35(4):512-24. DOI: 10.1177/0272989X14558423. View

20.

Alford D, Lazure P, Murray S, Hardesty I, Krause J, White J . National Trends in Prescription Opioid Risk Mitigation Practices: Implications for Prescriber Education. Pain Med. 2019; 20(5):907-915. DOI: 10.1093/pm/pny298. View